Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › ENGN

SR ONE CAPITAL MANAGEMENT, LP position in ENGN

ENGENE THERAPEUTICS INC · Health Care

SR ONE CAPITAL MANAGEMENT, LP reported holding 747,750 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 0.12% of its reported portfolio and ranking #15 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed ENGN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)747.75K sh
Reported value held$1.29M
Portfolio Weight0.12%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SR ONE CAPITAL MANAGEMENT, LP's ENGN position evolved

SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in ENGN in Q2 2024 at 500,000 shares (US$4.7M). The position peaked in Q4 2025 at 747,750 shares, worth US$6.8M. Across 9 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 747,750 shares valued at US$1.3M. Notable position changes include a 50% increase in Q3 2024.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 500.00K $4.71M New
Q3 2024 747.75K $4.94M Add
Q4 2024 747.75K $4.97M Hold
Q1 2025 747.75K $3.35M Hold
Q2 2025 747.75K $2.72M Hold
Q3 2025 747.75K $5.11M Hold
Q4 2025 747.75K $6.75M Hold
Q1 2026 747.75K $5.09M Hold
Q2 2026 747.75K $1.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENGN and 13F data

ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENGN

All ENGN fund holders →

FAQ

How long has SR ONE CAPITAL MANAGEMENT, LP held ENGN?

SR ONE CAPITAL MANAGEMENT, LP has disclosed ENGN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is SR ONE CAPITAL MANAGEMENT, LP's current position in ENGN?

As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 747.75K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $1.29M, representing 0.12% of its reported portfolio and ranking #15.

Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling ENGN?

In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in ENGN. The position peaked in Q4 2025 at 747.75K shares.

Which other funds hold ENGN?

Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.